Probing protein phosphatase substrate binding: affinity pull-down of ILKAP phosphatase 2C with phosphopeptides

Molecular BioSystems
Kim B Højlys-LarsenSteen Gammeltoft

Abstract

Proteomics and high throughput analysis for systems biology can benefit significantly from solid-phase chemical tools for affinity pull-down of proteins from complex mixtures. Here we report the application of solid-phase synthesis of phosphopeptides for pull-down and analysis of the affinity profile of the integrin-linked kinase associated phosphatase (ILKAP), a member of the protein phosphatase 2C (PP2C) family. Phosphatases can potentially dephosphorylate these phosphopeptide substrates but, interestingly, performing the binding studies at 4 °C allowed efficient binding to phosphopeptides, without the need for phosphopeptide mimics or phosphatase inhibitors. As no proven ILKAP substrates were available, we selected phosphopeptide substrates among known PP2Cδ substrates including the protein kinases: p38, ATM, Chk1, Chk2 and RSK2 and synthesized directly on PEGA solid supports through a BAL type handle. The results show that phosphopeptides tethered to a flexible solid support bind with high affinity and specificity to ILKAP, which is pulled down from lysates of cells transfected with ILKAP cDNA. Phosphorylation on Ser or Thr residues is important for binding of ILKAP, but sequences around the phosphorylated residue are impor...Continue Reading

References

Sep 28, 1982·Biochemistry·R B MerrifieldH G Boman
Jul 1, 1998·Annual Review of Biophysics and Biomolecular Structure·D BarfordM P Egloff
Jul 20, 1999·Molecular and Cellular Endocrinology·M Frödin, S Gammeltoft
Jan 27, 2000·Cell·T Hunter
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·M B Kastan, D S Lim
Oct 25, 2001·The Journal of Organic Chemistry·Gregory T. BourneMark L. Smythe
Dec 10, 2002·Science·G ManningS Sudarsanam
Jun 5, 2003·Cancer Cell·Jiri Bartek, Jiri Lukas
Jun 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sheng DingPeter G Schultz
Dec 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Klaus GodlHenrik Daub
Mar 3, 2004·Oncogene·Ashu S KumarGregory E Hannigan
Jun 10, 2004·Cell·Andres AlonsoTomas Mustelin
Jun 23, 2004·The Biochemical Journal·Ulrik DoehnClaus J Jensen
Apr 6, 2005·Biochemistry·Hiroshi YamaguchiEttore Appella
May 5, 2005·Genes & Development·Xiongbin LuLawrence A Donehower
Nov 29, 2005·Cell Death and Differentiation·H FujimotoY Minami
Feb 28, 2006·Chembiochem : a European Journal of Chemical Biology·Malene BrandtKnud J Jensen
Jul 11, 2006·Cancer Science·Shinri TamuraTakayasu Kobayashi
Jul 27, 2006·Journal of Cell Science·Camilla Hauge, Morten Frödin
Aug 10, 2006·Chemical Reviews·Michael J Evans, Benjamin F Cravatt
Sep 5, 2006·Molecular Cell·Sathyavageeswaran ShreeramDmitry V Bulavin
Dec 13, 2006·Journal of Molecular Evolution·Adi SternTal Pupko
Apr 5, 2007·Nature Protocols·Andrej ShevchenkoMatthias Mann
Apr 27, 2007·Molecular BioSystems·Fubo LiangZhong-Yin Zhang
Aug 28, 2007·Nature Biotechnology·Marcus BantscheffGerard Drewes
Dec 11, 2007·Critical Reviews in Biochemistry and Molecular Biology·Twan Lammers, Sara Lavi
Feb 13, 2008·Cancer Metastasis Reviews·Xiongbin LuLawrence A Donehower
May 20, 2008·Nucleic Acids Research·Qi Zheng, Xiu-Jie Wang
Sep 1, 2009·Current Opinion in Chemical Biology·Divya Krishnamurthy, Amy M Barrios
Oct 5, 2010·Current Protocols in Molecular Biology·Thomas McAvoy, Angus C Nairn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.